This course increases your knowledge and skills in pharmacology and biotechnology to increase your competitiveness in the job market or complete research at PhD level. If you are already employed, this course can help you to further your career prospects.
The course is delivered by internationally recognised academics who are involved in biotechnology and pharmacology research. Research projects include studying the manipulation of proteins and their application to Alzheimer's disease, epilepsy, ion channels and the development of novel drugs from natural products.
You learn in detail how drugs act at the molecular and cellular level and then how biotechnological techniques are used to produce new drugs. Examples include developing new and effective treatments for diseases, such as Alzheimer’s and rheumatoid arthritis.
You also gain experience of the latest techniques used by the pharmaceutical industry to produce and study the effects of novel drugs.
The course gives you
The masters (MSc) award is achieved by successfully completing 180 credits.
The postgraduate certificate (PgCert) is achieved by successfully completing 60 credits.
The postgraduate diploma (PgDip) is achieved by successfully completing 120 credits.
Assessment is mostly by written examination and coursework including problem solving exercises, case studies and input from practical laboratory work. Research project assessment includes a written report and viva voce.
The course improves your career prospects in areas of • biomedical sciences • medical research in universities and hospitals • the pharmaceutical industry • biotechnology companies • government research agencies.
You also develop the skills to carry out research to PhD level in pharmacology and biotechnology.
Recent MSc Pharmacology and Biotechnology graduates jobs include • project specialist at PAREXEL • quality assurance documentation assistant at Vifor Pharma • PhD at the University of Manchester • clinical research associate at AstraZeneca • workplace services analyst at Deloitte India (Offices of the US) • regulatory compliance specialist for Selerant • senior product executive at PlasmaGen BioSciences.
This programme teaches advanced experimental approaches to dissecting the mechanisms of drug action (pharmacology), a science that has seen innovative theoretical and technical development at UCL for over a century.
In addition to providing experience of both classical and modern pharmacological techniques, the programme will help develop skills for literature search-based data acquisition and analysis; written and verbal communication of science; abstract writing; poster preparation; graphical processing; image preparation for publication; writing a scientific paper; and giving research presentations.
Students undertake modules to the value of 180 credits.
The programme consists of three core modules (75 credits), one optional module (15 credits), and a research project (90 credits).
Students choose one of the following:
Students undertake an original research project which culminates in a 15,000-word dissertation and an oral presentation.
Teaching and learning
The programme is delivered through a combination of lectures, journal clubs, practicals, tutorials and a laboratory project. Student performance is evaluated through formal examination, coursework, and the research project.
Further information on modules and degree structure is available on the department website: Experimental Pharmacology and Therapeutics MSc
This programme is likely to lead to careers in biomedical sciences, the pharmaceutical and biotechnology industry and clinical laboratories, and extend to clinicians interested in moving towards a scientific career. Students will obtain a thorough knowledge of and practice in pharmacological assessment, drug design and development pathways. It is anticipated that graduates will move onto PhD programmes and/or build careers in industry or clinical investigations through employment as research associates/scientists in the pharmaceutical industry or academia.
The knowledge and transferable skills developed on this programme will be advantageous for those considering employment in any pharmaceutical or healthcare setting, or contemplating further studies in related fields. The programme will also provide excellent training in critical appraisal of complex data, which will transfer well to other disciplines.
The programme is jointly taught by UCL Neuroscience, Physiology & Pharmacology (Division of Biosciences), and the Research Department of Pharmacology at the UCL School of Pharmacy. Both departments are historically and currently internationally leading in this field, and together provide cutting-edge education in theory, research practice and innovation in pharmacology.
The programme is designed to impart extensive experimental expertise applied to drug development and subsequent therapeutics. The combination of traditional and experimental approaches in pharmacology, coupled with current innovation in therapeutics and drug discovery and development, fosters a unique set of skills, which will enable graduates of the programme to engage in various aspects of pharmaceutical research globally.
The Research Excellence Framework, or REF, is the system for assessing the quality of research in UK higher education institutions. The 2014 REF was carried out by the UK's higher education funding bodies, and the results used to allocate research funding from 2015/16.
The following REF score was awarded to the department: Division of Biosciences
82% rated 4* (‘world-leading’) or 3* (‘internationally excellent’)
Learn more about the scope of UCL's research, and browse case studies, on our Research Impact website.
The University of Aberdeen is highly regarded for Clinical Pharmacology as the discipline has been taught and delivered for 30 years and research spans 50 years. The programme draws on strengths within the university and medical area within disease discovery and treatment. The major innovation of Insulin was first developed at University of Aberdeen in the 1920s, winning the inventors a Nobel Prize and giving the world a major step forward in the management and regulation of insulin. Since this time the discovery of drug process, treatment and design has been developed and researched at Aberdeen. The University is also known for its research in food and nutrition, bacteria, gut issues researched at the world famous Rowett Institute and growing knowledge of disease process and latest innovative treatments.
Clinical pharmacology forms a critical part of the drug development process and our graduates are employed in the pharmaceutical and biotechnology industries. These industries are now in rapid growth due to a combination of innovations and strength within customised and other types of medicine and treatment industry areas. The industry is also a major contributor of GDP in the UK. Further innovations which link into this industry come from easier upscaling processes, customisation and the Internet of Things and more ability to treat and diagnose at source.
There is always a strong need for the discipline to provide a foundation to any new innovations which often come from multidisciplinary teams. Our aim is to train students in the major areas of clinical pharmacology including molecular pharmacology, drug metabolism and toxicology, therapeutics, pharmacokinetics, pharmcovigilance, regulatory affairs and experimental medicine. The programme aims to achieve this by a multi-disciplinary approach.
This programme is ideal for newly qualified graduates in medical science disciplines such as biomedical sciences, biochemistry, pharmacology, pharmacy, medicine and similar degrees. Careers can include work in clinical trials and NPD in pharmaceutical industries, doctoral research towards teaching, spin-outs and major innovations, regulation in the pharmaceutical industry and more.
Find out more detail by visiting the programme web page
Find out about fees
*Please be advised that some programmes have different tuition fees from those listed above and that some programmes also have additional costs.
View all funding options on our funding database via the programme page
Find out more about:
Find out more about living in Aberdeen and living costs
This study course is for students who wish to become specialised graduates with an advanced biomedical knowledge concerning the links between the structure and the purpose of biomolecules and bio-systems operating at cellular and tissue level of the human body, in both physiological and pathological conditions. The wide knowledge of the techniques is based on a solid practical activity in laboratories during the internship.
Subject to the educational aims of Class LM-9, the acquired knowledge allows specialized graduates to assist physicians in the diagnostic and therapeutic tasks involving the manipulation of cells, genes, and other biosystems requiring applicants to learn special skills in experimental biotechnology (e.g. Diagnosis and gene therapy; therapy through the use of genetically engineered cells; rational design and development of new medicines based on models of molecular targets known or derived from pharmacogenomic knowledge; preparation of nano-biotechnological tools for advanced diagnostics imaging and drug delivery; modulation of the immune response; diagnostics based on innovative processes of science and medical laboratory techniques; immunotherapy to targeted cells); organize and coordinate laboratory activities for advanced research or for diagnostic examinations requiring the use of biotechnological methods and the manipulation of cells or biotechnological materials; organize and coordinate the experimental protocols of clinical research involving the use of materials or biotechnology techniques; design and perform with autonomy research in biotechnology applied to medicine; lead and coordinate, also in governance, development programs and surveillance of biotechnology applied to human beings, taking into account the ethical, technical, environmental and economic implications.
First year: Advanced Biomedical Technologies Or Laboratory Activities 1: Cellular And Molecular Therapies Or Laboratory Activities 2: Molecular And Systems Biology, Laboratory Medicine Technologies And Molecular Diagnostics, Pharmaceutical Biotechnology: Design And Analysis Of Biopharmaceuticals, Seminar
Molecular Medicine Curriculum: 6 Months At Ulm University: Glp/Gsp Bioethics, Molecular Oncology, Trauma Research And Regenerative Medicine
Traditional Curriculum: Proteomics And Bioinformatics, Cell And Organ Physiology And Medical Pathophysiology, Genetics, Immunology And General Pathology, Nanobiotechnology
Second year: Experimental Models In Vivo And Vitro, Pharmacology And Molecular Therapies, Stem Cell Biology And Molecular Biology Of Development, Thesis Work
Molecular Medicine Curriculum + Proteomics And Bioinformatics
Biotechnology physicians will be able to head research laboratories in a predominantly technological and pharmacological environment and coordinate, as well as in terms of management and administration, program development and the monitoring of biotechnology applied on human beings with emphasis on the development of pharmaceutical products and vaccines, taking into account the ethical, technical, and legal implications and environmental protection.
Graduates will be able to assist doctors in the diagnostic and in the therapeutic phases when those imply the manipulation of cells, genes and other bio systems and when specific biotechnological experimental competences are required.
The University of Padova, the Veneto Region and other organisations offer various scholarship schemes to support students. Below is a list of the funding opportunities that are most often used by international students in Padova.
You can find more information below and on our website here: http://www.unipd.it/en/studying-padova/funding-and-fees/scholarships
You can find more information on fee waivers here: http://www.unipd.it/en/fee-waivers